Skip to main content
Fig. 2 | BMC Neurology

Fig. 2

From: A systematic review and meta-analysis on the efficacy outcomes of selective serotonin reuptake inhibitors in depression in Alzheimer’s disease

Fig. 2

The effect size for selective serotonin reuptake inhibitors impacts on depressive symptoms in AD patients shown by a forest plot of the standardized mean difference (SMD). The red squares represent the pooled effects for each research subgroup, whereas the green square represents the overall pooled impact. Each study’s SMD is shown by a black square. 95% confidence intervals are represented by horizontal lines (CI)

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us